Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients
Titel:
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients
Auteur:
Barrichello, Adriana P.C. Elkrief, Arielle Ricciuti, Biagio Ganta, Teja Marron, Thomas U. Wang, Xinan Lotter, William Lindsay, James Santo, Valentina Cortellini, Alessio Sharma, Bijaya Felt, Kristen Pfaff, Kathleen Lamberti, Giuseppe Pecci, Federica Federico, Alessandro Di Makarem, Maisam Gandhi, Malini M. Nguyen, Tom Haradon, Danielle Vaz, Victor R. Johnson, Bruce E. Debnath, Neha Wang, Yinghong Kuang, Andrew G. Saeed, Anwaar Radford, Maluki Lovly, Christine M. Nebhan, Caroline A. Pinato, David J. Rodig, Scott J. Schoenfeld, Adam J. Awad, Mark M. Alessi, Joao V. Naqash, Abdul Rafeh